Sundrug Co.,Ltd.

(株)サンドラッグ

9989.T

Pharmaceutical Retailers

2026/08/24 Updated

Market Cap: $2.7B (¥437.5B)

Stock Price: $23.49 (¥3,740)

Exchange Rate: 1 USD = ¥159.24

Stock Price Chart

2026/08/24 Updated

13.94

PER (Price Earnings Ratio)

vs Industry Avg: +4.4

1.53

PBR (Price to Book Ratio)

vs Industry Avg: +0.2

3.56%

Dividend Yield

vs Industry Avg: +0.61%

Price Trend

2026/08/24 Updated

Short-term

5-Day MA

+1.25%

Near-term

25-Day MA

-0.55%

Mid-term

75-Day MA

-0.66%

Long-term

200-Day MA

-5.51%

Price & Trading Details

2026/08/24 Updated

PRICE

Previous Close ¥3,712

Open ¥3,735

High ¥3,759

Low ¥3,717

Close ¥3,740

TRADING

Volume 339,700

Average Volume 556,546

Turnover ¥13億

Min. Purchase ¥374,000

Analyst Recommendations 7 analysts

Updated 2026/08/01

Strong Buy

Buy

Hold

Sell

Strong Sell

Target Price (Mean)

¥4,753

Buy

¥5,600

High

¥5,000

Median

¥3,970

Low

+12% vs Current Price

This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Earnings Calendar

Updated 2026/08/01

AUG

2026

Next Earnings Release

Q3 FY2026

EPS Estimate: ¥68.59

Recent Earnings

Date	EPS Est.	EPS Actual	Surprise
2026/05/15	¥-138.42	¥61.21	+144.2%
2026/02/12	¥83.20	¥76.61	-7.9%
2025/11/13	¥60.19	¥62.62	+4.0%
2025/08/14	¥68.59	¥67.92	-1.0%

Shareholder Composition

Updated 2026/08/01

41.4%

Insider Holdings

22.7%

Institutional

36.0%

Public Float

119

Institutional Holders

Insider Holdings 41.4%

Institutional 22.7%

Public Float 36.0%

Major Holders

Updated 2026/08/01

Institution	Ownership	Shares	Change
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund	0.82%	976.3K	0.00%
Goldman Sachs TRT-Goldman Sachs Intl Small Cap Insights Fd.	0.78%	936.0K	-11.91%
Columbia Funds Series Trust-Columbia Overseas Value Fund	0.78%	925.1K	+4.48%
MFS Series Trust V-MFS International New Discovery Fund	0.55%	658.2K	0.00%
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund	0.55%	651.7K	+2.18%
iShares Trust-iShares Core MSCI EAFE ETF	0.45%	540.0K	0.00%

Dividend History

Updated 2026/08/23

Dividend Yield

¥66

Annual Dividend

-49.2%

YoY Growth

24.6%

Payout Ratio

Year	Dividend	Change
2026	¥66	-49.2%
2025	¥130	+6.6%
2024	¥122	+14.0%
2023	¥107	+24.4%
2022	¥86	-

Financial Performance

2026/08/23 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

	2022	2023	2024	2025
Income Statement
Revenue	¥648,734M	¥690,462M	¥751,777M	¥801,811M
Gross Profit	¥156,506M	¥171,946M	¥189,319M	¥204,087M
Operating Income	¥34,052M	¥37,455M	¥41,000M	¥44,500M
Pretax Income	¥34,684M	¥37,746M	¥41,293M	¥43,733M
Net Income	¥23,853M	¥25,703M	¥29,126M	¥30,750M
EPS	¥204.01	¥219.82	¥249.07	¥262.91
Operating Margin	5.25%	5.42%	5.45%	5.55%
Balance Sheet
Total Assets	¥325,768M	¥360,672M	¥420,208M	¥444,007M
Total Equity	¥220,592M	¥236,327M	¥253,089M	¥269,714M
Total Liabilities	¥105,176M	¥124,345M	¥167,119M	¥174,293M
Cash	¥89,330M	¥80,872M	¥69,698M	¥64,956M
Interest-bearing Debt	-	¥0M	¥35,000M	¥38,666M
Equity Ratio	67.71%	65.52%	60.23%	60.75%
D/E Ratio	0.00	0.00	0.14	0.14
Cash Flow
Operating CF	¥31,682M	¥37,380M	¥41,188M	¥41,164M
Investing CF	-¥20,659M	-¥28,512M	-¥74,850M	-¥35,373M
Financing CF	-¥8,187M	-¥17,326M	¥22,487M	-¥10,600M
Free CF	¥11,893M	¥11,267M	¥2,963M	¥6,898M
Efficiency
ROE	10.81%	10.88%	11.51%	11.40%
ROA	7.32%	7.13%	6.93%	6.93%